Earnings playbook: Reporting season gets underway with JPMorgan Chase, Netflix on deck

Nearly 28 S&P 500 companies report this week, with major banks (Bank of America, JPMorgan, Goldman Sachs, Morgan Stanley) and large defensives (Johnson & Johnson, UnitedHealth) plus Netflix and others on deck. Consensus points to S&P 500 June-quarter profits up 23.3% YoY, implying a second consecutive quarter of >20% EPS growth, while bank-specific expectations range from BoA earnings growth of >25% YoY to Goldman >30% YoY and Morgan Stanley >35% YoY. News flow is dominated by elevated expectations and investor sensitivity to Fed-rate concerns, making individual prints potentially market-moving for financials and key holdings.

Analysis

This week is less about a clean macro read and more about whether the market is already over-earning from a handful of high-quality franchises. The banks are the main transmission mechanism: if NII and trading/IB commentary hold up, that supports the idea that rates are still high enough to keep asset sensitivity positive and markets active enough to sustain fee income, which should favor large-cap financials over regionals. The catch is that strong prints may still fail to lift stocks if capital-return visibility stays clouded; that is the key reason single-name gaps can be muted even when fundamentals are fine.

Among the non-banks, the setup is more idiosyncratic. UNH is the cleaner compounder because cost-out can translate into margin expansion over 6-18 months, but the market needs evidence that the savings are actually durable rather than headline promises. JNJ is more of a quality-defense name; upside depends on whether newer launches can offset portfolio erosion, while downside comes from any sign that the pipeline won’t reaccelerate growth, which would keep the multiple capped.

NFLX remains the most asymmetric in the wrong direction if engagement and monetization diverge after price increases: the stock can absorb mediocre subscriber optics, but not a message that pricing power is outrunning retention. Contrarian view: consensus may be underestimating how much good news is already embedded in the banks, while overestimating the risk that Netflix needs a huge subscriber beat to work. The cleaner trade is relative strength in financials versus a defensive basket, with defined-risk bearish exposure to NFLX only if implied vol is not already expensive. Falsifiers: a downside revision to bank NII/guidance, any explicit pause in buybacks from capital concerns, or a clearly constructive Netflix ad-tier/retention update that supports a multiple reset higher.

Key Decisions for Investors

• Go long XLF vs. SPY for the 1-3 day earnings window; thesis is that strong bank fundamentals plus elevated market activity should support sector relative performance even if individual names gap modestly. Falsify if JPM/BAC/MS all guide NII below the high end or flag capital pressure.
• Pair trade: long MS / short JPM into the prints, with a 1-2 week horizon. MS has the cleaner mix of wealth-fee sensitivity and market leverage; JPM faces a higher bar because any cautious EPS framing or regulatory-capital commentary can suppress upside.
• Buy a defined-risk UNH call spread for the 1-3 month window if the stock weakens on the print but management reiterates 2026 AI-driven cost savings. Risk/reward favors a delayed rerating if medical cost trends stay contained and savings credibility improves.
• For NFLX, consider a small bearish put spread only if implied volatility is not already pricing a large move. The thesis is that post-price-hike scrutiny around churn/engagement can still compress the multiple; stop out if management shows ad-tier or retention upside.
• Stay underweight JNJ vs. XLV on a 1-3 month basis until newer-product launch commentary converts into measurable revenue acceleration. If launches fail to offset mature-franchise erosion, the stock remains a bond proxy with limited re-rating power.